Your browser doesn't support javascript.
loading
Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches.
Lepak, A J; Trang, M; Hammel, J P; Sader, H S; Bhavnani, S M; VanScoy, B D; Pogue, J M; Ambrose, P G; Andes, D R.
  • Lepak AJ; University of Wisconsin-Madison, Department of Medicine, Madison, Wisconsin, USA.
  • Trang M; Institute for Clinical Pharmacodynamics, Schenectady, New York, USA.
  • Hammel JP; Institute for Clinical Pharmacodynamics, Schenectady, New York, USA.
  • Sader HS; JMI Laboratories, North Liberty, Iowa, USA.
  • Bhavnani SM; Institute for Clinical Pharmacodynamics, Schenectady, New York, USA.
  • VanScoy BD; Institute for Clinical Pharmacodynamics, Schenectady, New York, USA.
  • Pogue JM; University of Michigan, Ann Arbor, Michigan, USA.
  • Ambrose PG; Institute for Clinical Pharmacodynamics, Schenectady, New York, USA.
  • Andes DR; University of Wisconsin-Madison, Department of Medicine, Madison, Wisconsin, USA.
Antimicrob Agents Chemother ; 67(4): e0145222, 2023 04 18.
Article en En | MEDLINE | ID: mdl-36946729

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Acinetobacter baumannii / Neumonía Asociada al Ventilador / Antiinfecciosos Tipo de estudio: Guideline / Prognostic_studies Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Acinetobacter baumannii / Neumonía Asociada al Ventilador / Antiinfecciosos Tipo de estudio: Guideline / Prognostic_studies Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article